NIVALIS THERAPEUTICS INC's ticker is NVLS and the CUSIP is 65481J109. A total of 47 filers reported holding NIVALIS THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $894,000 | -25.6% | 371,049 | -9.8% | 0.00% | – |
Q1 2017 | $1,201,000 | +166.9% | 411,229 | +104.7% | 0.00% | – |
Q4 2016 | $450,000 | -79.6% | 200,904 | -26.1% | 0.00% | – |
Q3 2016 | $2,208,000 | +87.9% | 271,682 | +6.4% | 0.00% | – |
Q2 2016 | $1,175,000 | +5.3% | 255,420 | -4.5% | 0.00% | – |
Q1 2016 | $1,116,000 | -45.2% | 267,569 | +1.7% | 0.00% | – |
Q4 2015 | $2,035,000 | -21.5% | 262,975 | +31.6% | 0.00% | – |
Q3 2015 | $2,592,000 | +328.4% | 199,879 | +400.5% | 0.00% | – |
Q2 2015 | $605,000 | – | 39,936 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 1,546,743 | $6,450,000 | 1.60% |
TIGER MANAGEMENT L.L.C. | 650,915 | $2,714,000 | 0.68% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,732,412 | $15,564,000 | 0.66% |
RA Capital Management | 612,863 | $2,556,000 | 0.33% |
WALL STREET ASSOCIATES | 170,400 | $711,000 | 0.30% |
Opaleye Management Inc. | 100,000 | $417,000 | 0.26% |
Rock Springs Capital Management LP | 489,000 | $2,039,000 | 0.17% |
SABBY MANAGEMENT, LLC | 662,058 | $2,761,000 | 0.14% |
SPHERA FUNDS MANAGEMENT LTD. | 79,900 | $333,000 | 0.07% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 256,552 | $1,070,000 | 0.06% |